4//SEC Filing
Krishnamurthy Nirup 4
Accession 0001104659-24-004104
CIK 0001622879other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:07 PM ET
Size
7.0 KB
Accession
0001104659-24-004104
Insider Transaction Report
Form 4
Krishnamurthy Nirup
Chief Operating Officer
Transactions
- Purchase
Common Stock
2023-11-21$0.61/sh+10,000$6,141→ 1,610,000 total - Purchase
Common Stock
2023-11-29$0.59/sh+6,600$3,893→ 1,616,600 total
Footnotes (2)
- [F1]Issued as restricted stock units (RSUs) in connection with reporting persons retainer as director under the Company's 2017 Equity Incentive Plan and exempt from Section 16(b) by virtue of Rule 16(b)-b(d)(1) and (3). The 1,600,000 RSU's are reportable, however, as directly owned shares of common stock, rather as a derivative security in Table II, because any and all underlying RSUs are payable, at such time as they are to be settled, solely in common stock. See Lincoln National Corp. (March 20, 1992) (Q.3).
- [F2]The options vest in four (4) equal annual installments on each anniversary of the grant date, beginning on May 24, 2023.
Documents
Issuer
Medicine Man Technologies, Inc.
CIK 0001622879
Entity typeother
Related Parties
1- filerCIK 0001825865
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:07 PM ET
- Size
- 7.0 KB